Development

Moving Beyond Particle Size Control

Particle engineering enables pipeline molecules to achieve their full potential.

QbD Helps Evaluate Excipient Variability

Applying a QbD approach helps address excipient variability and other quality features.

Spray-Dried Dispersion Formulation

In-vitro and in-silico tools can help predict in-vivo outcomes.

Securing Each Dose

Dosage-level authentication provides an added digital layer of security.

Biden Administration Invests in Antiviral Medicines

June 18, 2021

The US government will invest $3 billion from the American Rescue Plan into a COVID-19 antiviral development strategy.

GSK and iTeos Therapeutics Enter mAb Collaboration

June 18, 2021

GlaxoSmithKline and iTeos Therapeutics enter into a development and commercialization collaboration worth up to $2.08 billion for a new therapeutic anti-cancer mAb candidate.

Evonik and Stanford University Partner to Develop mRNA Drug Delivery Technology

June 16, 2021

Evonik and Stanford University have signed a research collaboration to develop and market a new drug delivery platform for mRNA and gene therapy.

Process Development Improvements Post-Pandemic

June 15, 2021

What can the biopharma industry learn from its rapid response to the COVID-19 pandemic?

DFE Pharma Becomes Newest Partner in MMIC Collaboration

June 11, 2021

CPI has revealed an agreement with DFE Pharma, making it the latest partner of the Medicines Manufacturing Innovation Centre (MMIC) collaboration.

Novel Automated Process May Speed Up Development of New Medicines

June 11, 2021

Researchers from the Chalmers University of Technology and AstraZeneca have developed a new method of detecting and testing lipid nanoparticles.

Lab-Scale Capsule Filler Provides Flexibility for Dosing Small Quantities

June 10, 2021

New features of Syntegon’s GKF 60 capsule filler include a piezo dosing system, an Automated Process Development tool, and quick changeover to containment.

VIVEbiotech Launches Lentiviral Vector Manufacturing Plant for Cell and Gene Therapies

June 08, 2021

VIVEbiotech has opened its new lentiviral vector manufacturing facilities in Spain, expanding capacity for lentiviral vectors for use in cell and gene therapies.

Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for NASH Treatment

June 08, 2021

FDA has granted fast track designation to a GLP-1/glucagon dual agonist in development by Boehringer Ingelheim and Zealand Pharma for the treatment of NASH.

Janssen Receives FDA Breakthrough Therapy Designation for Multiple Myeloma mAb

June 08, 2021

FDA has granted Janssen breakthrough therapy designation for teclistamab, an investigational bispecific antibody under development for treating relapsed or refractory multiple myeloma.